TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
BCAX

Bicara Therapeutics Inc.

Healthcare · Biotechnology

18.60$ +0.3% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Bicara Therapeutics Inc. (BCAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 512 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BCAX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 234 209 209 524 569 478 454 425 431 554 512
– 231 206 206 522 503 471 444 297 422 545 504
– 230 204 204 521 490 462 437 172 97 323 97
– 230 204 204 521 490 462 437 290 415 540 497
– 15 16 384 15 77 19 18 22 30 40 43
– 15 16 16 14 18 19 17 21 29 39 43
– 0.3 0.3 0.3 0.3 0.6 0.6 1.1 1.1 1.1 1.1 1.2
– 3.2 4.7 4.7 2.0 4.5 2.7 2.9 3.7 7.8 7.4 8.5
– 219 193 -175 510 492 459 435 403 401 514 469
– -153 -183 -183 -200 -221 -258 -285 -322 -359 -415 -471
54 53 54 54 54 54 54 55 55 55 61 68

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?